| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 06/23/2011 | WO2011073269A1 Piperidine aryl sulfonamide derivatives as kv1.3 modulators |
| 06/23/2011 | WO2011073119A1 Mk2 inhibitors |
| 06/23/2011 | WO2011072496A1 Epothilone compounds, preparation method and use thereof |
| 06/23/2011 | WO2011072483A1 Compositions and methods for controlling proliferation and differentiation cells |
| 06/23/2011 | WO2011022539A9 Methods for administration of colchicine with grapefruit juice |
| 06/23/2011 | WO2011022394A3 Materials and methods for the development of an antigen-specific immune non-responsiveness state |
| 06/23/2011 | WO2010144502A9 Growth hormone polypeptides and methods of making and using same |
| 06/23/2011 | US20110154521 Transgenic animals expressing antibodies specific for genes of interest and uses thereof |
| 06/23/2011 | US20110152338 Cycloalkane[b]indole antagonists of prostaglandin d2 receptors |
| 06/23/2011 | US20110152321 Bicyclic derivatives useful as inhibitors of dpp-1 |
| 06/23/2011 | US20110152320 Pyrrole derivatives, their preparation and their therapeutic application |
| 06/23/2011 | US20110152296 Heterocyclic compounds and their uses |
| 06/23/2011 | US20110152291 Novel aromatic compounds and their use in medical applications |
| 06/23/2011 | US20110152290 Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals |
| 06/23/2011 | US20110152287 Substituted benzothiazole and benzoxazole derivatives useful as inhibitors of dpp-1 |
| 06/23/2011 | US20110152277 Heterocyclic compounds and their uses |
| 06/23/2011 | US20110152276 Substituted pyrrolo[2,3-d]pyrimidines as antifolates |
| 06/23/2011 | US20110152260 Indazole derivatives as modulators of interleukin-1 receptor-associated kinase |
| 06/23/2011 | US20110152250 Chromanylurea compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor and uses thereof |
| 06/23/2011 | US20110152243 Novel thienopyrrole compounds |
| 06/23/2011 | US20110152241 Novel compounds as receptor modulators with therapeutic utility |
| 06/23/2011 | US20110152238 Pharmaceutical compounds |
| 06/23/2011 | US20110152236 Azetidine polysubstituted compounds, preparation thereof, and therapeutic application thereof |
| 06/23/2011 | US20110152226 Development of New Selective Estrogen Receptor Modulators |
| 06/23/2011 | US20110152222 Use of 2,5-dihydroxybenzene derivatives for the treatment of arthritis and pain |
| 06/23/2011 | US20110152220 Methods of diagnosing, preventing and treating bone mass diseases |
| 06/23/2011 | US20110152217 Polymorphs of (s)-3-aminomethyl-7-(3-hydroxy-propoxy)-3h-benzo[c][1,2]oxaborol-1-ol |
| 06/23/2011 | US20110152209 Core 2 GlcNAc-T Inhibitors |
| 06/23/2011 | US20110152195 Post irradiation shelf-stable dual paste direct injectable bone cement precursor systems and methods of making same |
| 06/23/2011 | US20110152174 Inhibition of secretion from non-neuronal cells |
| 06/23/2011 | US20110152173 TNF-a ANTAGONIST MULTI-TARGET BINDING PROTEINS |
| 06/23/2011 | US20110152171 Histamine binding protein |
| 06/23/2011 | US20110152169 Sparc anti-inflammatory activity and uses thereof |
| 06/23/2011 | US20110151579 Secreted Epithelial Stromal-1 Molecules and Uses Thereof |
| 06/23/2011 | US20110151480 Methods of purifying zsig33 |
| 06/23/2011 | US20110151434 Adeno-associated virus (aav) sequences and isolating novel sequences identified thereby |
| 06/23/2011 | US20110151027 Strontium-doped calcium phosphate bone graft materials |
| 06/23/2011 | US20110151026 Bone tissue implant comprising lithium ions |
| 06/23/2011 | US20110151022 Thiotungstate analogues and uses thereof |
| 06/23/2011 | US20110151016 Use of angiogenin or angiogenin agonists for treating diseases and disorders |
| 06/23/2011 | US20110150978 Ph-sensitive block copolymer forming polyionic complex micelles and drug or protein carrier using the same |
| 06/23/2011 | US20110150962 Therapeutic agent capsule for implants |
| 06/23/2011 | US20110150894 Methods of modulating angiogenesis via trpv4 |
| 06/23/2011 | US20110150873 Anti-inflammatory compositions and combinations |
| 06/23/2011 | US20110150872 Soluble heterodimeric cytokine receptor |
| 06/23/2011 | US20110150866 Compositions and Methods for Increasing Bone Mineralization |
| 06/23/2011 | US20110150865 Antibodies to lymphotoxin-alpha |
| 06/23/2011 | US20110150864 Substituted aminothiazolone indazoles as estrogen related receptor-alpha modulators |
| 06/23/2011 | US20110150860 Novel 25869, 25934, 26335, 50365, 21117, 38692, 46508, 16816, 16839, 49937, 49931 and 49933 molecules and uses therefor |
| 06/23/2011 | US20110150847 Method of three-dimensionally culturing chondrocytes |
| 06/23/2011 | US20110150834 Crth2 modulators |
| 06/23/2011 | US20110150833 Benzopyrans and analogs as rho kinase inhibitors |
| 06/23/2011 | US20110150830 Covalent conjugates between endoperoxides and transferrin and lactoferrin receptor-binding agents |
| 06/23/2011 | US20110150825 Uses of selective inhibitors of hdac8 for treatment of inflammatory conditions |
| 06/23/2011 | US20110150821 Methods and crosslinked polymer compositions for cartilage repair |
| 06/23/2011 | US20110150763 Triazine derivatives and their therapeutical applications |
| 06/23/2011 | US20110150757 Compounds for inhibiting ksp kinesin activity |
| 06/23/2011 | CA2784566A1 Heterocyclic compounds and their uses |
| 06/23/2011 | CA2780290A1 Mk2 inhibitors |
| 06/22/2011 | EP2336321A1 Ox2 receptor homolog |
| 06/22/2011 | EP2336297A2 Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues |
| 06/22/2011 | EP2336179A1 Stabilized single domain antibodies |
| 06/22/2011 | EP2336168A1 Novel protein and method for producing the protein |
| 06/22/2011 | EP2336167A1 MHC molecule constructs and their uses for diagnosis and therapy |
| 06/22/2011 | EP2336111A1 Heterocyclic inhibitors of p38 |
| 06/22/2011 | EP2335726A1 Fusion molecules and methods for treatment of immune diseases |
| 06/22/2011 | EP2335709A1 Insulin resistance improving agent |
| 06/22/2011 | EP2335704A1 Pharmaceutical composition comprising a strontium salt, vitamine D and a cyclodextrine |
| 06/22/2011 | EP2334378A2 Prodrugs of methyl hydrogen fumarate, pharmaceutical compositions thereof, and methods of use |
| 06/22/2011 | EP2334312A1 Compositions comprising plant extracts and use thereof for treating inflammation |
| 06/22/2011 | EP2334308A1 Treating or preventing gout |
| 06/22/2011 | EP2334304A1 Therapeutic bone growth and regeneration |
| 06/22/2011 | EP2334293A2 Compositions comprising polyhydroxyltate fatty alcohol derivatives and the therapeutic uses |
| 06/22/2011 | EP1979334B1 Novel benzamidine derivatives, process for the preparation thereof and pharmaceutical composition comprising the same |
| 06/22/2011 | EP1341526B1 Pharmaceutical compositions for the oral delivery of calcitonin |
| 06/22/2011 | EP1204683B1 Ovarian cancer cell and myeloma cell surface glycoproteins, antibodies thereto, and uses thereof |
| 06/22/2011 | CN1887309B Extraction of effective red sage components for preventing and treating osteoporosis and depression |
| 06/22/2011 | CN1447819B Human CYR 61 |
| 06/22/2011 | CN102105472A Novel compounds useful for the treatment of degenerative and inflammatory diseases |
| 06/22/2011 | CN102105471A Novel compounds useful for the treatment of degenerative and inflammatory diseases |
| 06/22/2011 | CN102105153A Method for treating hyperuricemia employing an SGLT2 inhibitor and composition containing same |
| 06/22/2011 | CN102102066A Cortex acanthopanacis yellow rice wine and production technology thereof |
| 06/22/2011 | CN102101863A Novel epoxy thiazone compounds and preparation method and application thereof |
| 06/22/2011 | CN102100907A Composition of oral pharmacologic active agent |
| 06/22/2011 | CN102100897A Preparation technology and preparation method of novel integrative Erchen decoction dosage form |
| 06/22/2011 | CN102100887A Preparation technology of new integrative formulation of kudzuvine root decoction and preparation method thereof |
| 06/22/2011 | CN102100881A Traditional Chinese medicine composition for treating arthralgia |
| 06/22/2011 | CN102100868A Medicinal liquor for treating scapulohumeral periarthritis |
| 06/22/2011 | CN102100866A Chinese medicinal composition for treating lumbar intervertebral disc protrusion |
| 06/22/2011 | CN102100854A Chinese medicinal composition for treating rheumatic arthritis |
| 06/22/2011 | CN102100853A Traditional Chinese medicine for treating gout and preparation method thereof |
| 06/22/2011 | CN102100852A Preparation technology and production method of integrated Baihu decoction novel dosage form |
| 06/22/2011 | CN102100849A Chinese medicine preparation for treating lumbar disc herniation and preparation method thereof |
| 06/22/2011 | CN102100811A Chinese medicine capsule for treating rheumatoid arthritis of dogs and cats |
| 06/22/2011 | CN102100774A Green and natural Chinese medicine powder for foot bath and health care |
| 06/22/2011 | CN102100768A Preparation technique for ephedra decoction in novel formed formulation and production method thereof |
| 06/22/2011 | CN102100759A Traditional Chinese medicine composition with functions of tonifying liver and kidney and treating hyperosteogeny |
| 06/22/2011 | CN102100757A Qingpeng spray preparation for relieving pain and swelling and preparation method thereof |
| 06/22/2011 | CN102100754A Chinese medicinal composition for treating osteoproliferation |
| 06/22/2011 | CN102100726A Chinese medicinal composition for treating heel pain |